Stock 2269 WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Delayed Hong Kong S.E.
Other stock markets
 11:46:11 2024-04-18 pm EDT 		5-day change 1st Jan Change
12.7 HKD -4.08% Intraday chart for WuXi Biologics (Cayman) Inc. -8.63% -57.09%
Apr. 01 Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer CI
Mar. 27 WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump MT

Evolution of the average Target Price on WuXi Biologics (Cayman) Inc.

Price target over the last 5 years

History of analyst recommendation changes

03992b13e324b4754b6397f.9iUm26Evzhsr6YQuf-oZANPrc-NJa64gFr7gUCE7fGA.vhZivOR4ikpNsfIZGaJBdrndBYJxGoNqV-rSJ2R_LVDPdHO56nrjSX-44w~216a5a7957639cbe66e4f29aceea5b31

Analyst Recommendations on WuXi Biologics (Cayman) Inc.

Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy MT
Hong Kong Stocks Rebound Over Unchanged Fed Rates; Wuxi Up 3% MT
Nomura Adjusts Wuxi Biologics’ Price Target to HK$58.44 From HK$82.69, Keeps at Buy MT
Nomura Adjusts Wuxi Biologics' Price Target to HK$82.69 From HK$86.68, Keeps at Buy MT
Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$86.86 From HK$94.91, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$94.91 From HK$97.78, Keeps at Buy MT
New energy shares drag China stocks lower, Fed rate-decision jitters weigh RE
UBS Adjusts Wuxi Biologics’ Price Target to HK$113.12 From HK$110.67, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$97.78 From HK$95.75, Keeps at Buy MT
UBS Adjusts Wuxi Biologics (Cayman)'s Price Target to HK$95.75 From HK$100.87, Keeps at Buy MT
China stocks rise on higher-than-expected borrowing rate cut; foreign inflows surge RE
UBS Adjusts Wuxi Biologics' Price Target to HK$110.67 From HK$142, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$100.87 From HK$103.28, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$103.28 From HK$149.92, Keeps at Buy MT
China stocks fall as virus worries, Fed rate hike bets weigh; Hong Kong up RE
WUXI BIOLOGICS CAYMAN : Nomura Adjusts WuXi Biologics' Price Target to HK$116.8 From HK$213.1, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
12.24 CNY
Average target price
28.39 CNY
Spread / Average Target
+131.95%
High Price Target
67.84 CNY
Spread / Highest target
+454.36%
Low Price Target
11.08 CNY
Spread / Lowest Target
-9.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering WuXi Biologics (Cayman) Inc.

Nomura
UBS

Ratings for WuXi Biologics (Cayman) Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. Consensus WuXi Biologics (Cayman) Inc.